Potential Therapeutic Targets of Quercetin, a Plant Flavonol, and Its Role in the Therapy of Various Types of Cancer through the Modulation of Various Cell Signaling Pathways
Top Cited Papers
Open Access
- 1 March 2021
- Vol. 26 (5), 1315
- https://doi.org/10.3390/molecules26051315
Abstract
Polyphenolic flavonoids are considered natural, non-toxic chemopreventers, which are most commonly derived from plants, fruits, and vegetables. Most of these polyphenolics exhibit remarkable antioxidant, anti-inflammatory, and anticancer properties. Quercetin (Qu) is a chief representative of these polyphenolic compounds, which exhibits excellent antioxidant and anticancer potential, and has attracted the attention of researchers working in the area of cancer biology. Qu can regulate numerous tumor-related activities, such as oxidative stress, angiogenesis, cell cycle, tumor necrosis factor, proliferation, apoptosis, and metastasis. The anticancer properties of Qu mainly occur through the modulation of vascular endothelial growth factor (VEGF), apoptosis, phosphatidyl inositol-3-kinase (P13K)/Akt (proteinase-kinase B)/mTOR (mammalian target of rapamycin), MAPK (mitogen activated protein kinase)/ERK1/2 (extracellular signal-regulated kinase 1/2), and Wnt/β-catenin signaling pathways. The anticancer potential of Qu is documented in numerous in vivo and in vitro studies, involving several animal models and cell lines. Remarkably, this phytochemical possesses toxic activities against cancerous cells only, with limited toxic effects on normal cells. In this review, we present extensive research investigations aimed to discuss the therapeutic potential of Qu in the management of different types of cancers. The anticancer potential of Qu is specifically discussed by focusing its ability to target specific molecular signaling, such as p53, epidermal growth factor receptor (EGFR), VEGF, signal transducer and activator of transcription (STAT), PI3K/Akt, and nuclear factor kappa B (NF-κB) pathways. The anticancer potential of Qu has gained remarkable interest, but the exact mechanism of its action remains unclear. However, this natural compound has great pharmacological potential; it is now believed to be a complementary—or alternative—medicine for the prevention and treatment of different cancers.Keywords
This publication has 321 references indexed in Scilit:
- ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for Urothelial Carcinoma—Neoadjuvant and Adjuvant SettingsEuropean Urology, 2013
- Cardioprotective Effects of Quercetin in Cardiomyocyte under Ischemia/Reperfusion InjuryEvidence-Based Complementary and Alternative Medicine, 2013
- Quercetin increased bioavailability and decreased methylation of green tea polyphenols in vitro and in vivoFood & Function, 2012
- Cancer immunotherapy via dendritic cellsNature Reviews Cancer, 2012
- Two-stage model-based design of cancer phase I dose escalation trials: evaluation using the phase I program of barasertib (AZD1152)Investigational New Drugs, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Phosphatidylinositol 3-Kinase: The OncoproteinCurrent Topics in Microbiology and Immunology, 2010
- Phytoestrogen consumption and endometrial cancer risk: a population-based case–control study in New JerseyCancer Causes & Control, 2009
- Effects of low dose quercetin: Cancer cell‐specific inhibition of cell cycle progressionJournal of Cellular Biochemistry, 2008
- The Hallmarks of CancerCell, 2000